Want to see AU:IRE full AI Analyst Report?
Top Page
IRESS Limited
(Sydney:IRE)
Select Model
Select Model
Rating:59Neutral
Price Target:
AU$6.50
â–¼(-8.32% Downside)
Action:Reiterated
Date:02/26/26
The score is driven primarily by improving financial health (profitability recovery and lower leverage), tempered by weakening revenue and cash-flow momentum. Technicals are the main drag given a clear downtrend versus moving averages and a negative MACD, while valuation provides partial support through a reasonable P/E and moderate dividend yield.
Positive Factors
Improving leverage
Material de‑risking of the balance sheet meaningfully reduces financing risk and interest burden. Lower leverage and rebuilt equity provide greater covenant headroom and flexibility to fund product development, M&A or return capital, improving long‑term resilience versus prior cycles.
Negative Factors
Sustained revenue decline
Two consecutive years of revenue contraction weaken operating leverage and signal market share or demand pressures. Persistent top‑line decline constrains margin expansion, limits reinvestment capacity, and heightens execution risk for growth initiatives over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage
Material de‑risking of the balance sheet meaningfully reduces financing risk and interest burden. Lower leverage and rebuilt equity provide greater covenant headroom and flexibility to fund product development, M&A or return capital, improving long‑term resilience versus prior cycles.
Read all positive factors
IRESS Limited (IRE) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$1.16B
Dividend Yield2.47%
Average Volume (3M)699.46K
Price to Earnings (P/E)14.9
Beta (1Y)0.84
Revenue Growth-7.41%
EPS Growth-11.47%
CountryAU
Employees1,153
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)0.42
Shares Outstanding186,789,470
10 Day Avg. Volume572,677
30 Day Avg. Volume699,458
Financial Highlights & Ratios
PEG Ratio-1.90
Price to Book (P/B)3.73
Price to Sales (P/S)2.84
P/FCF Ratio31.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$10.35Price Target Upside45.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.45
Revenue Forecast (FY)AU$515.35M
IRESS Limited Business Overview & Revenue Model
Company Description
Iress Limited engages in the designing and developing software and services for the financial services industry in the Asia Pacific, the United Kingdom and Europe, South Africa, and North America. It offers client management, business automation, ...
How the Company Makes Money
IRESS primarily makes money by licensing its financial software platforms and providing ongoing access under subscription/recurring arrangements (commonly contracted with enterprise clients), typically including ongoing maintenance, support, and p...
IRESS Limited Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
68
Positive
Cash Flow
54
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 556.32M | 600.83M | 625.74M | 615.59M | 595.95M |
| Gross Profit | 148.63M | 124.22M | 96.38M | 167.51M | 138.59M |
| EBITDA | 119.29M | 154.85M | -54.28M | 119.95M | 146.39M |
| Net Income | 79.26M | 88.67M | -137.48M | 52.67M | 73.80M |
Balance Sheet | |||||
| Total Assets | 670.12M | 730.22M | 792.22M | 1.00B | 1.03B |
| Cash, Cash Equivalents and Short-Term Investments | 55.35M | 66.19M | 50.74M | 63.81M | 64.87M |
| Total Debt | 164.10M | 234.03M | 422.96M | 462.75M | 389.38M |
| Total Liabilities | 247.01M | 352.12M | 520.21M | 566.25M | 495.71M |
| Stockholders Equity | 423.10M | 378.11M | 272.01M | 433.81M | 536.91M |
Cash Flow | |||||
| Free Cash Flow | 49.62M | 82.91M | 44.24M | 84.97M | 77.08M |
| Operating Cash Flow | 62.63M | 104.57M | 63.66M | 112.58M | 101.21M |
| Investing Cash Flow | 25.59M | 129.56M | 25.79M | -31.96M | -34.56M |
| Financing Cash Flow | -101.69M | -213.43M | -108.25M | -77.85M | -64.39M |
IRESS Limited Technical Analysis
Neutral
7.09
Price Trends
6.15
Positive
6.58
Negative
7.53
Negative
Market Momentum
0.05
Negative
53.27
Neutral
55.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IRE, the sentiment is Neutral. The current price of 7.09 is above the 20-day moving average (MA) of 6.23, above the 50-day MA of 6.15, and below the 200-day MA of 7.53, indicating a neutral trend. The MACD of 0.05 indicates Negative momentum. The RSI at 53.27 is Neutral, neither overbought nor oversold. The STOCH value of 55.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:IRE.
IRESS Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$1.06B | 27.02 | 42.94% | 10.16% | -12.00% | -45.47% | |
68 Neutral | AU$10.08B | 71.63 | 32.19% | 0.83% | 14.48% | 6.31% | |
65 Neutral | AU$665.47M | 23.49 | 25.65% | 1.27% | 6.51% | 15.45% | |
64 Neutral | AU$48.76M | 6.59 | 7.40% | 5.97% | -4.94% | -64.96% | |
64 Neutral | AU$703.46M | -737.20 | -0.72% | ― | 10.99% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | AU$1.16B | 14.90 | 19.57% | 2.47% | -7.41% | -11.47% |
* Technology Sector Average
AU:IRE
IRESS Limited
6.31
-1.14
-15.25%
AU:IRI
Integrated Research Limited
0.27
-0.20
-42.80%
AU:TNE
Technology One Limited
30.80
-8.03
-20.68%
AU:BVS
Bravura Solutions Limited
2.36
0.31
15.35%
AU:OCL
Objective Corporation Limited
6.96
-11.04
-61.33%
AU:FCL
FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh
2.04
-0.64
-23.88%
IRESS Limited Corporate Events
IRESS Cancels Over 1.3 Million Lapsed Equity Incentive Rights
Jul 9, 2026
IRESS Limited has announced the lapse of a total of more than 1.3 million equity-linked incentives, comprising share appreciation rights and performance rights that have ceased because their vesting conditions were not, or could no longer be, sati...
IRESS Issues New Unquoted Equity Rights Under Employee Incentive Schemes
Jul 9, 2026
IRESS Limited has issued new unquoted equity securities under its employee incentive schemes, comprising 165,112 share appreciation rights and 379,709 performance rights. These securities, which are not intended to be quoted on the ASX, form part ...
IRESS issues 357,071 new shares on conversion of unquoted equity
Jul 9, 2026
IRESS Limited has notified the market of the issue and transfer of 357,071 ordinary fully paid shares following the conversion or exercise of previously unquoted equity securities. The new shares, effective from 1 April 2026, reflect the company&#...
Iress shifts registered office to new Melbourne headquarters
Jun 22, 2026
Iress Limited has relocated its registered office and principal place of business to Level 32, 555 Collins Street, Melbourne, while retaining its existing telephone contact details. The change, effective immediately, signals a new corporate base f...
Iress boosts CEO equity incentives with new share appreciation rights grant
May 12, 2026
Iress Limited has granted CEO Andrew John Russell 890,322 share appreciation rights under its long-term incentive plan for the 2026 financial year. The award, which carries no cash consideration, was approved at the company’s annual general ...
IRESS issues 1.99m unquoted share appreciation rights under employee scheme
May 12, 2026
IRESS Limited has notified the market of the issue of 1,990,332 unquoted share appreciation rights under its employee incentive scheme, effective 11 May 2026. The rights, which are not intended to be quoted on the ASX, represent a continuation of ...
IRESS cancels 107,713 performance rights after vesting conditions lapse
May 12, 2026
IRESS Limited has advised the market that 107,713 performance rights, issued under its equity incentive arrangements and trading under the ASX code IREAA, have lapsed after vesting conditions were not met or became incapable of being satisfied as ...
Iress taps Thoughtworks to fast-track AI-led overhaul of wealth platforms
May 7, 2026
Iress has entered a strategic partnership with global technology consultancy Thoughtworks to accelerate the modernisation of its core wealth management platforms and embed AI capabilities across its software suite. The collaboration combines Iress...
Iress shareholders back all resolutions at 2026 AGM
Apr 24, 2026
Iress Limited reported that all resolutions put to shareholders at its 2026 Annual General Meeting were passed by poll, reflecting strong investor support for the company’s current governance and remuneration settings. Shareholders comfortab...
Iress resets around core software businesses as profits rise and new CEO takes helm
Apr 23, 2026
Iress Limited reported a stronger FY25 after simplifying its operations around its core Wealth and Trading Market Data software businesses, delivering higher revenue, profit and EBITDA, and materially reducing leverage through an asset sale progr...
IRESS Issues New Shares Following Conversion of Unquoted Securities
Apr 15, 2026
IRESS Limited has notified the market of the issue of 21,619 ordinary fully paid shares following the conversion or exercise of previously unquoted securities. The new shares, which were issued on 31 March 2026, modestly increase the company’...
IRESS Issues New Tranche of Unquoted Share Appreciation Rights
Apr 15, 2026
IRESS Limited has notified the market of the issue of 296,556 unquoted share appreciation rights under its employee incentive scheme. The securities, which are not intended to be quoted on the ASX, were issued on 26 March 2026 and reflect the comp...
IRESS Clears Over 1.9 Million Lapsed Equity Incentives From Capital Structure
Apr 15, 2026
IRESS Limited has notified the market that a series of equity-based incentive instruments, including share appreciation rights, performance rights, deferred share rights and options, have lapsed as of 31 March 2026 because their vesting or perform...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.